期刊文献+

利鲁唑对吗啡躯体依赖的影响及其可能机制

Effects and possible mechanisms of riluzole on withdrawal syndrome in morphine-dependent mice and rats
原文传递
导出
摘要 目的 :评价利鲁唑对吗啡躯体依赖的调节作用及可能机制。方法 :在小鼠吗啡依赖和大鼠依赖模型上分析利鲁唑对吗啡躯体依赖的影响。用化学发光法测定小鼠脑组织NOS活性。结果 :在小鼠吗啡躯体依赖模型中 ,利鲁唑 (2 .5~ 1 0mg/kg ,sc)剂量依赖性地抑制吗啡依赖小鼠纳洛酮催促的戒断症状 ;在大鼠吗啡依赖模型中 ,利鲁唑 (2 .5和 5mg/kg,sc)使吗啡依赖大鼠纳洛酮催促戒断积分明显降低。利鲁唑能显著降低吗啡依赖小鼠不同脑区(大脑、小脑、丘脑 )一氧化氮合酶 (NOS)活性。结论 :利鲁唑抑制吗啡依赖大鼠和小鼠的戒断症状 。 Objective:To study the influence and the possible mechanisms of riluzole on the physical dependence on morphine.Methods:The influence of riluzole on morphine dependence was studied in mice and rats in vivo . NOS activity was determined as a measure of concentration of NO, using a direct NOS assay kit. Results:In morphine dependent model of mice, withdrawal syndrome induced by naloxone was inhibited by co_administration of riluzole (2.5-10?mg/kg, sc) with morphine in a dose dependent manner. In morphine dependent model of rats, co_administration of riluzole (2.5 and 5?mg/kg, sc) with morphine could inhibit the rat abstinent syndrome induced by naloxone significantly. Naloxone induced an increase in NOS activity in cerebrum, thalamus and cerebellum of morphine_dependent mice, co_pretreatment of mice with morphine and riluzole inhibited this effect induced by naloxone. Conclusions:The results indicated that riluzole was able to inhibit substance dependence on morphine in mice and rats, which was related with its inhibitory action on NOS activity.
出处 《军事医学科学院院刊》 CSCD 北大核心 2003年第3期189-192,共4页 Bulletin of the Academy of Military Medical Sciences
关键词 利鲁唑 吗啡 物质戒断综合征 躯体依赖 一氧化氮合酶 riluzole morphine substance withdrawal syndrome substance dependence nitric_oxide synthase
  • 相关文献

参考文献20

  • 1李锦.阿片功能调节剂[J].中国药理学会通讯,2002,19(1):14-15. 被引量:2
  • 2Coderre TJ. Potent analgesia induced in rats by cambined action at PCP and polyamine recognition sites of the NMDA receptor complex[J]. Eur J Neurosei, 1993,5(4) :390 - 393.
  • 3Kretschmer BD, Kratzer U, Schmidt WJ. Riluzole, a glutamate release inhibilor, and motor behavior[J]. Naunyn Schmiedeberg's Arch Pharmacol, 1998,358(2) : 181 - 190.
  • 4Debono MW, Le Guern J, Canton T, et al. Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes[J]. Eur J Pharmacol, 1993,235(2 - 3) :283 - 289.
  • 5Lips J, de Haan P, Bodewits P, et al. Neuroprotective effects of riluzole mad ketamine during transient spinal cord ischemia in the rabbit[J]. Anesthesiology, 2000, 93(5) : 1303 - 1311.
  • 6Mizoule J, Meldrum B, Mazadier M, et al. 2-Amino-6-trifluorome-thoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission-I. Anticonvulsant properties [ J ]. Neuropharmacology, 1985,24(8 ) : 767 - 773.
  • 7Mantz J, Cheramy A, Thierry AM, et al. Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission[J]. Anesthesiology, 1992,76(5) :844 - 848.
  • 8Stutzmann JM, Cintrat P, Laduron PM, et al. Riluzole antagonizes the anxingenic properties of the beta-carboline FG 7142 in rats[J].Psychopharmacology (Berl), 1989,99(4) :515 - 519.
  • 9Doble A. The pharmacology and mechanism of action of riluzole[J].Neurology, 1996,47(6 Suppl 4) :S233 - S241.
  • 10Li J, Li X, Pei G, et al. Effects of agmatine on tolerance to and substance dependence on morphine mice[ J]. Zhongguo Yao Li Xue Bao, 1999,20(3) :232 -238.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部